Fady Ibraham Malik - May 7, 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Malik
Stock symbol
CYTK
Transactions as of
May 7, 2024
Transactions value $
-$917,645
Form type
4
Date filed
5/7/2024, 04:37 PM
Previous filing
Apr 15, 2024
Next filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $94.6K +14.2K +10.25% $6.67* 153K May 7, 2024 Direct F1
transaction CYTK Common Stock Sale -$924K -14.2K -9.3% $65.11 138K May 7, 2024 Direct F1
transaction CYTK Common Stock Sale -$88.6K -1.36K -0.98% $65.11 137K May 7, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Incentive Stock Option (Right to Buy) Options Exercise $0 -14.2K -100% $0.00* 0 May 7, 2024 Common Stock 14.2K $6.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.